Companies / Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc

Nasdaq: VNDACIK 1347178WASHINGTON, DC

Financials · FY2025

Revenue$216.10M
Net income$-220.47M
Total debt—
Cash$55.88M
Diluted EPS$-3.74
Shares outstanding60.5M

Ownership

60.5M shares outstanding · as of Jul 30, 2026
8.2%Insiders
Ownership
Insiders8.23%4,978,509
10%+ / strategic10.37%6,267,125
Institutions72.76%43,993,928
Public float8.64%5,223,125

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Polymeropoulos Mihael HristosCEOPresident and CEO · Director
4.47%2,704,496
Birznieks GuntherSVP, Business Development
0.82%494,197
Moran Kevin PatrickSVP, CFO & Treasurer
0.68%411,380
Williams TimothySVP & General Counsel
0.62%377,450
Wijkstrom JoakimSVP, Chief Marketing Officer
0.55%333,469
Dugan Richard WDirector
0.36%219,054
Chrousos PhaedraDirector
0.27%164,950
Ward Anne SempowskiDirector
0.27%160,667
Honore TageFormerDirector
0.22%135,069
Mitchell Stephen RayDirector
0.19%112,846

Institutional holders 167

View all →
HolderValue% of shares
BlackRock, Inc.$46.84M12.66%
Vanguard Group Inc$32.91M6.17%
Renaissance Technologies LLC$25.98M6.22%
State Street Corporation$21.52M5.82%
Dimensional Fund Advisors LP$18.68M3.50%
Millennium Management LLC$13.00M3.11%
AIGH Capital Management LLC$12.51M3.38%
AQR Capital Management, LLC$11.08M2.65%
Geode Capital Management, LLC$9.97M2.39%
Empire Financial Management Company, LLC$9.77M1.83%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 2, 2026Polymeropoulos Mihael Hristos
CEO
SellCommon Stock$1.28M-156K
-5.46%
2,704,496
4.47% of shares
medium
Mar 2, 2026Moran Kevin Patrick
Executive
SellCommon Stock$350.8K-42K
-9.35%
411,380
0.68% of shares
medium
Mar 2, 2026Williams Timothy
Executive
SellCommon Stock$350.8K-42K
-10.11%
377,450
0.62% of shares
medium
Mar 2, 2026Birznieks Gunther
Executive
SellCommon Stock$350.7K-42K
-7.91%
494,197
0.82% of shares
medium
Mar 2, 2026Wijkstrom Joakim
Executive
SellCommon Stock$254.6K-31K
-8.46%
333,469
0.55% of shares
medium
Feb 23, 2026Honore Tage
Director
SellCommon Stock$240.9K-30K
-24.30%
93,469
0.15% of shares
medium
Jun 4, 2026McGuire Daniel Patrick
Executive
GrantCommon Stock$0+80K
+266.83%
109,982
0.18% of shares
low
Jun 4, 2026Chrousos Phaedra
Director
GrantCommon Stock$0+42K
+33.73%
164,950
0.27% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Millennium Management LLCPassive13G/A———
BlackRock Portfolio Management LLCPassive13G/A—3,251,563—
BlackRock Portfolio Management LLCPassive13G/A—2,508,488—
State Street CorporationPassive13G—3,015,562—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
VNDA——921659108—